6 assets in Gestational Trophoblastic Neoplasm

Therapeutic assets addressing Gestational Trophoblastic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Domvanalimab Gestational Trophoblastic Neoplasm	Hospices Civils de Lyon	P2	CCC (53)
Ipilimumab Gestational Trophoblastic Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Nivolumab Gestational Trophoblastic Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Sctil Gestational Trophoblastic Neoplasm	Peking Union Medical College Hospital	P2	CCC (53)
Toripalimab Gestational Trophoblastic Neoplasm	Peking Union Medical College Hospital	P2	CCC (53)
Zimberelimab Gestational Trophoblastic Neoplasm	Hospices Civils de Lyon	P2	CCC (53)